WASHINGTON (AP) — U.S. health regulators want makers of popular anti-diarrhea drugs to sell their tablets in smaller amounts to make them harder to abuse.
The request comes amid a spike in overdoses from large doses of the over-the-counter drugs, which contain a small amount of an opioid.
The Food and Drug Administration said Tuesday it is asking manufacturers to package their medications in smaller quantities, such as eight tablets per package. Currently, some generic versions are sold in boxes of up to 200 tablets.
The key ingredient in anti-diarrhea medications like Imodium is part of the opioid family, an addictive drug class that includes morphine and oxycodone. At low doses, the medicine helps control diarrhea. But recent statistics show a rise in abuse of massive doses to try and get high.
Most Read Business Stories
- Some bosses want workers back in the office despite COVID. Here's why
- Chaos at Sea-Tac Airport still a risk despite 5G wireless deal
- Tax season 2022: What to know about child credit and stimulus payments
- Microsoft buys game maker Activision Blizzard for about $70B
- In tiny Wyoming town, Bill Gates bets big on nuclear power